The Codes Requiring Service Authorization spreadsheet has been updated. The following drugs will require SA effective May 1, 2024.
- Alyglo™ (immune globulin, human-stwk) J1599 Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg
- Asceniv™ (immune globulin(human)-slra) J1554 Injection, immune globulin (asceniv), 500 mg
- Cutaquig® (immune globulin(human)-hipp) J1551 Injection, immune globulin (cutaquig), 100 mg
- Cuvitru (immune globulin (human)) J1555 Injection, immune globulin (cuvitru), 100 mg
- Gammaplex® (immune globulin(human)) J1557 Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg
- Panzyga® (immune globulin (human)ifas) J1576 Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg
- Xembify® (immune globulin (human)-klhw) J1558 Injection, immune globulin (xembify), 100 mg
Date of Update
Update Category
Provider Type
Provider Year
2024